CoChat

RETRACTED: Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients

Sato, Y, Honda, Y, Kuno, H, Oizumi, K · 1998 · Bone

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Significant reduction in bone mineral density (BMD) occurs in stroke patients on the hemiplegic and contralateral sides, correlating with the degree of paralysis and vitamin D and K deficiency due to malnutrition, and increasing the risk of hip fracture. We evaluated the efficacy of vitamin K2 (menatetrenone: menaquinone-4; MK-4) in maintaining BMD by comparing serum biochemical indices of bone metabolism between treated and untreated patients. In a random and prospective study, of 108 hemiplegic patients following stroke, 54 received 45 mg menatetrenone daily (MK-4 group, n = 54) for 12 months, and the remaining 54 (untreatment group) did not. Nine patients excluded from the study. The BMD in the second metacarpals and serum indices of bone metabolism were determined. BMD on the hemiplegic side increased by 4.3% in the MK-4 group and decreased by 4.7% in the untreated group (p < 0.0001), while BMD on the intact side decreased by 0.9% in the MK-4 group and by 2.7% in the untreated group (p < 0.0001). At baseline, patients of both groups showed vitamin D and K1 deficiencies, high serum levels of ionized calcium, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), and low levels of parathyroid hormones (PTH) and bone Gla proteins (BGP), indicating that immobilization-induced hypercalcemia inhibits renal synthesis of 1, 25-dihydroxyvitamin D (1, 25-[OH]2D) and compensatory PTH secretion. Both vitamins K1 and K2 increased by 97.6% and 666.9%, respecti…

Overview

Integrity signals

Registry

Crossref · 10.1016/s8756-3282(98)00108-2This paper is marked retracted.

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

6 retracted

Show all 34 references

Research works printed but not linked: 3

  1. Claus-Walker, 1975, Bone metabolism in quadriplegia, Arch Phys Med Rehabil, 56, 327
  2. Matsumoto, 1991, A new computed X-ray densitometer and its performance (in Japanese with English abstract), J Clin Exp Med, 156, 741
  3. Orimo, 1992, Clinical evaluation of menatetrenone in the treatment of involuntional osteoporosis—A double-blind multicenter comparative study, J Bone Miner Res, 7, S122

Cited by

See all 77

Metadata

Authors
Sato, Y., Honda, Y., Kuno, H., & Oizumi, K.
Affiliations
  • Social Insurance Futase Hospital (JP)
  • Kurume University (JP)
Venue
Bone
Publisher
Elsevier BV
Published
1998-09
Volume
23
Issue
3
Pages
291-296
ISSN
  • 1873-2763 (ISSN-L)
  • 8756-3282
OpenAlex
W2162201507
Cited by
77
References
33
Citations by year
2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 2 · 2015: 1 · 2014: 1 · 2012: 3
FWCI
3.58
Type
journal article
Language
en
Status
Retracted
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Bone (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
menatetrenone, menaquinone-4, vitamin K2, osteopenia, bone mineral density, stroke, hemiplegia, disuse, immobilization, vitamin D deficiency, vitamin K deficiency, bone metabolism, parathyroid hormone, 1,25-dihydroxyvitamin D, osteocalcin, C-terminal telopeptide of type I collagen, hip fracture prevention
MeSH terms
Aged, Bone Diseases, Metabolic, Cerebrovascular Disorders, Female, Hemiplegia, Hemostatics, Humans, Male, Metacarpus, Middle Aged, Vitamin K 1, Prospective Studies, Vitamin D Deficiency, Vitamin K, Vitamin K Deficiency, Biomarkers, Bone Density, Vitamin K 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED: Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. https://app.cochat.ai/papers/10.1016/s8756-3282(98)00108-2
The paper
Sato, Y., Honda, Y., Kuno, H., & Oizumi, K. (1998). RETRACTED: Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. https://doi.org/10.1016/s8756-3282(98)00108-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.